Adipose tissue dysfunction in nascent metabolic syndrome

Journal of Obesity

Volumn 2013, Issue , 2013, Pages

  Bremer, Andrew A ^a   Jialal, Ishwarlal ^b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CHEMERIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; RETINOL BINDING PROTEIN 4; SERUM AMYLOID A;

ADIPOSE TISSUE; HUMAN; MACROPHAGE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SUBCUTANEOUS FAT; BLOOD; CARDIOVASCULAR DISEASE; INFLAMMATION; INSULIN RESISTANCE; PATHOPHYSIOLOGY; SECRETION (PROCESS);

ADIPOKINES; ADIPOSE TISSUE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; SUBCUTANEOUS FAT;

MLCS; MLOWN;

EID: 84877277282     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2013/393192     Document Type: Review

References (60)

1. Reaven G. M., The insulin resistance syndrome: definition and dietary approaches to treatment. Annual Review of Nutrition 2005 25 391 406 2-s2.0-22844449583 10.1146/annurev.nutr.24.012003.132155 (Pubitemid 41209007)
2. Eckel R. H., Grundy S. M., Zimmet P. Z., The metabolic syndrome. Lancet 2005 365 9468 1415 1428 2-s2.0-17144380822 10.1016/S0140-6736(05)66378-7 (Pubitemid 40523737)
3. Haffner S. M., Cassells H. B., Metabolic syndrome-a new risk factor of coronary heart disease? Diabetes, Obesity and Metabolism 2003 5 6 359 370 2-s2.0-0344034796 10.1046/j.1463-1326.2003.00290.x (Pubitemid 37483597)
4. Cornier M. A., Dabelea D., Hernandez T. L., Lindstrom R. C., Steig A. J., Stob N. R., Van Pelt R. E., Wang H., Eckel R. H., The metabolic syndrome. Endocrine Reviews 2008 29 7 777 822 2-s2.0-57349096045 10.1210/er.2008-0024
5. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 2001 285 19 2486 2497 2-s2.0-0035897696 (Pubitemid 32433843)
6. Mozumdar A., Liguori G., Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 2011 34 1 216 219 2-s2.0-79951704858 10.2337/dc10-0879
7. Alexander C. M., Landsman P. B., Teutsch S. M., Haffner S. M., NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003 52 5 1210 1214 2-s2.0-0037407403 10.2337/diabetes.52.5.1210 (Pubitemid 36523358)
8. Alberti K. G. M. M., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J. C., James W. P. T., Loria C. M., Smith S. C., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation 2009 120 16 1640 1645 2-s2.0-70350245011 10.1161/CIRCULATIONAHA.109.192644
9. Schmidt C., Bergstrom G. M., The metabolic syndrome predicts cardiovascular events: results of a 13-year follow-up in initially healthy 58-year-old men. Metabolic Syndrome and Related Disordoers 2012 10 6 394 399
10. Lakka H. M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., Salonen J. T., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 2002 288 21 2709 2716 2-s2.0-0037021505 10.1001/jama.288.21. 2709 (Pubitemid 35403784)
11. Hanson R. L., Imperatore G., Bennett P. H., Knowler W. C., Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002 51 10 3120 3127 2-s2.0-0036787485
12. Assmann G., Nofer J. R., Schulte H., Cardiovascular risk assessment in metabolic syndrome: view from PROCAM. Endocrinology and Metabolism Clinics of North America 2004 33 2 377 392 2-s2.0-2542497015 10.1016/j.ecl.2004.03.017 (Pubitemid 38680635)
13. Devaraj S., Rosenson R.S., Jialal I., Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinology and Metabolism Clinics of North America 2004 33 431 453 10.1016/j.ecl.2004.03.00810.1016/j.ecl. 2004.03.017 (Pubitemid 38680638)
14. Devaraj S., Siegel D., Jialal I., Byrne C. D., Wild S.H., Inflammation and metabolic syndrome. The Metabolic Syndrome 2011 2nd ch 13 Wiley-Blackwell 210 228
15. Northcott J. M., Yeganeh A., Taylor C. G., Zahradka P., Wigle J. T., Adipokines and the cardiovascular system: mechanisms mediating health and disease. Canadian Journal of Physiology and Pharmacology 2012 90 8 1029 1059
16. Bluher M., Clinical relevance of adipokines. Diabetes and Metabolism Journal 2012 36 5 317 327
17. Jialal I., Devaraj S., Huet B. A., Chen X., Kaur H., Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2012 97 10 E1844 E1850
18. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
19. Monteiro R., Azevedo I., Chronic inflammation in obesity and the metabolic syndrome. Mediators of Inflammation 2010 2010 10 2-s2.0-77955362775 10.1155/2010/289645 289645
20. Despres J. P., Lemieux S., Lamarche B., Prud'Homme D., Moorjani S., Brun L. D., Gagne C., Lupien P. J., The insulin resistance dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. International Journal of Obesity 1995 19 1, supplement S76 S86 2-s2.0-0029074972
21. Després J. P., Is visceral obesity the cause of the metabolic syndrome? Annals of Medicine 2006 38 1 52 63 2-s2.0-31744443753 10.1080/07853890500383895 (Pubitemid 43177788)
22. Fox C. S., Massaro J. M., Hoffmann U., Pou K. M., Maurovich-Horvat P., Liu C. Y., Vasan R. S., Murabito J. M., Meigs J. B., Cupples L. A., D'Agostino R. B., O'Donnell C. J., Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the framingham heart study. Circulation 2007 116 1 39 48 2-s2.0-34347351228 10.1161/CIRCULATIONAHA. 106.675355 (Pubitemid 47016245)
23. Porter S. A., Massaro J. M., Hoffmann U., Vasan R. S., O'Donnel C. J., Fox C. S., Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 2009 32 6 1068 1075 2-s2.0-66549117879 10.2337/dc08-2280
24. Goodpaster B. H., Thaete F. L., Simoneau J. A., Kelley D. E., Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997 46 10 1579 1585 2-s2.0-0030765908 (Pubitemid 27411233)
25. Abate N., Garg A., Peshock R. M., Stray-Gundersen J., Grundy S. M., Relationships of generalized and regional adiposity to insulin sensitivity in men. Journal of Clinical Investigation 1995 96 1 88 98 2-s2.0-0029087640
26. Abate N., Garg A., Peshock R. M., Stray-Gundersen J., Adams-Huet B., Grundy S. M., Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996 45 12 1684 1693 2-s2.0-0029862540 (Pubitemid 26398946)
27. Ferreira I., Henry R. M. A., Twisk J. W. R., Van Mechelen W., Kemper H. C. G., Stehouwer C. D. A., The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness. The Amsterdam Growth and Health Longitudinal Study. Archives of Internal Medicine 2005 165 8 875 882 2-s2.0-17744378195 10.1001/archinte.165.8.875 (Pubitemid 40575728)
28. Salmenniemi U., Ruotsalainen E., Pihlajamäki J., Vauhkonen I., Kainulainen S., Punnonen K., Vanninen E., Laakso M., Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004 110 25 3842 3848 2-s2.0-11144346107 10.1161/01.CIR.0000150391. 38660.9B (Pubitemid 40023983)
29. Carr D. B., Utzschneider K. M., Hull R. L., Kodama K., Retzlaff B. M., Brunzell J. D., Shofer J. B., Fish B. E., Knopp R. H., Kahn S. E., Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004 53 8 2087 2094 2-s2.0-3242795814 10.2337/diabetes.53.8.2087 (Pubitemid 38970759)
30. Apovian C. M., Bigornia S., Mott M., Meyers M. R., Ulloor J., Gagua M., McDonnell M., Hess D., Joseph L., Gokce N., Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 9 1654 1659 2-s2.0-51649088497 10.1161/ATVBAHA.108.170316
31. Bremer A. A., Devaraj S., Afify A., Jialal I., Adipose tissue dysregulation in patients with metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2011 96 11 E1782 E1788
32. Devaraj S., Jialal G., Cook T., Siegel D., Jialal I., Low vitamin D levels in Northern American adults with the metabolic syndrome. Hormone and Metabolic Research 2011 43 1 72 74 2-s2.0-78650724452 10.1055/s-0030-1268485
33. Anderson E. K., Gutierrez D. A., Hasty A. H., Adipose tissue recruitment of leukocytes. Current Opinion in Lipidology 2010 21 3 172 177 2-s2.0-77952419815 10.1097/MOL.0b013e3283393867
34. Surmi B. K., Hasty A. H., Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidology 2008 3 5 545 556 2-s2.0-55849130382 10.2217/17460875.3.5.545
35. Wood I. S., De Heredia F. P., Wang B., Trayhurn P., Cellular hypoxia and adipose tissue dysfunction in obesity. Proceedings of the Nutrition Society 2009 68 4 370 377 2-s2.0-77949329629 10.1017/S0029665109990206
36. Gormez S., Demirkan A., Atalar F., Caynak B., Erdim R., Sozer V., Gunay D., Akpinar B., Ozbek U., Buyukdevrim A. S., Adipose tissue gene expression of adiponectin, tumor necrosis factor- α and leptin in metabolic syndrome patients with coronary artery disease. Internal Medicine 2011 50 8 805 810 2-s2.0-79955565366 10.2169/internalmedicine.50.4753
37. Sacks H. S., Fain J. N., Cheema P., Bahouth S. W., Garrett E., Wolf R. Y., Wolford D., Samaha J., Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone. Diabetes Care 2011 34 3 730 733 2-s2.0-79956127761 10.2337/dc10-2083
38. Hajer G. R., Van Haeften T. W., Visseren F. L. J., Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008 29 24 2959 2971 2-s2.0-58049219012 10.1093/eurheartj/ehn387
39. Fantuzzi G., Mazzone T., Adipose tissue and atherosclerosis: exploring the connection. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 5 996 1003 2-s2.0-34247325960 10.1161/ATVBAHA.106.131755 (Pubitemid 46641984)
40. Deng Y., Scherer P. E., Adipokines as novel biomarkers and regulators of the metabolic syndrome. Annals of the New York Academy of Sciences 2010 1212 E1 E19 2-s2.0-79952259618
41. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., Okamoto Y., Ohashi K., Nagaretani H., Kishida K., Nishizawa H., Maeda N., Kobayashi H., Hiraoka H., Matsuzawa Y., Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003 107 5 671 674 2-s2.0-0037432152 10.1161/01.CIR.0000055188.83694.B3 (Pubitemid 36222590)
42. Venugopal S. K., Devaraj S., Jialal I., Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. American Journal of Pathology 2005 166 4 1265 1271 2-s2.0-17144369225 (Pubitemid 40524449)
43. Huang-Doran I., Sleigh A., Rochford J. J., O'Rahilly S., Savage D. B., Lipodystrophy: metabolic insights from a rare disorder. Journal of Endocrinology 2010 207 3 245 255 2-s2.0-78650055830 10.1677/JOE-10-0272
44. Mitchell C., Couton D., Couty J. P., Anson M., Crain A. M., Bizet V., Rénia L., Pol S., Mallet V., Gilgenkrantz H., Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. American Journal of Pathology 2009 174 5 1766 1775 2-s2.0-65649094468 10.2353/ajpath.2009.080632
45. Ito A., Suganami T., Yamauchi A., Degawa-Yamauchi M., Tanaka M., Kouyama R., Kobayashi Y., Nitta N., Yasuda K., Hirata Y., Kuziel W. A., Takeya M., Kanegasaki S., Kamei Y., Ogawa Y., Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. Journal of Biological Chemistry 2008 283 51 35715 35723 2-s2.0-58149102605 10.1074/jbc.M804220200
46. Ernst M. C., Sinal C. J., Chemerin: at the crossroads of inflammation and obesity. Trends in Endocrinology and Metabolism 2010 21 11 660 667 2-s2.0-78049314118 10.1016/j.tem.2010.08.001
47. Bozaoglu K., Segal D., Shields K. A., Cummings N., Curran J. E., Comuzzie A. G., Mahaney M. C., Rainwater D. L., Vandeberg J. L., MacCluer J. W., Collier G., Blangero J., Walder K., Jowett J. B. M., Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. Journal of Clinical Endocrinology and Metabolism 2009 94 8 3085 3088 2-s2.0-68549109421 10.1210/jc.2008-1833
48. Sell H., Divoux A., Poitou C., Basdevant A., Bouillot J. L., Bedossa P., Tordjman J., Eckel J., Clément K., Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Journal of Clinical Endocrinology and Metabolism 2010 95 6 2892 2896 2-s2.0-77954471976 10.1210/jc.2009-2374
49. Sell H., Laurencikiene J., Taube A., Eckardt K., Cramer A., Horrighs A., Arner P., Eckel J., Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009 58 12 2731 2740 2-s2.0-73249122917 10.2337/db09-0277
50. Stejskal D., Karpisek M., Hanulova Z., Svestak M., Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomedical Papers of the Medical Faculty of the University Palacký Olomouc, Czechoslovakia 2008 152 2 217 221 2-s2.0-62449203154
51. Chu S. H., Lee M. K., Ahn K. Y., Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS ONE 2012 7 4 e34710
52. Dong B., Ji W., Zhang Y., Elevated serum chemerin levels are associated with the Presence of coronary artery disease in patients with metabolic syndrome. Internal Medicine 2011 50 10 1093 1097 2-s2.0-79957616277 10.2169/internalmedicine.50.5025
53. Weigert J., Neumeier M., Wanninger J., Filarsky M., Bauer S., Wiest R., Farkas S., Scherer M. N., Schäffler A., Aslanidis C., Schölmerich J., Buechler C., Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology 2010 72 3 342 348 2-s2.0-76649090026 10.1111/j.1365-2265.2009.03664.x
54. Schäffler A., Neumeier M., Herfarth H., Fürst A., Schölmerich J., Büchler C., Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochimica et Biophysica Acta 2005 1732 1-3 96 102 2-s2.0-33144479356 10.1016/j.bbaexp.2005.11.005 (Pubitemid 43267310)
55. Tan B. K., Adya R., Randeva H. S., Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends in Cardiovascular Medicine 2010 20 5 143 148 2-s2.0-79960078829 10.1016/j.tcm.2010.12.002
56. De Souza Batista C. M., Yang R. Z., Lee M. J., Glynn N. M., Yu D. Z., Pray J., Ndubuizu K., Patil S., Schwartz A., Kligman M., Fried S. K., Gong D. W., Shuldiner A. R., Pollin T. I., McLenithan J. C., Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007 56 6 1655 1661 2-s2.0-34249674520 10.2337/db06-1506 (Pubitemid 46842600)
57. Shang F. J., Wang J. P., Liu X. T., Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 2011 16 8 657 662
58. Gremese E., Ferraccioli G., The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmunity Reviews 2011 10 10 582 589
59. Jialal I., Devaraj S., Kaur H., Huet B. A., Bremer A. A., Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2013
60. Jialal I., Huet B. A., Kaur H., Chien A., Devaraj S., Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care 2012 35 4 900 904